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Abstract: Malignant pleural effusions (MPE) are a common clinical problem in patients with neoplastic disease. 
Pleural fluid cytology is the simplest definitive method for obtaining a diagnosis of MPE. We describe a method 
that may increase the cancer cell detection rate using immunomagnetic separation in MPE. In comparison to 
standard MPE cytodiagnostic methods, we report a more streamlined method of isolation living cells that are 
able to proliferate. These captured cells can then be used for additional downstream analysis e.g. chemosen-
sitivity testing. Several case studies of MPE diagnostics using immunomagnetic separation are presented in the 
following report. The immunomagnetic separation of cancer cells from MPE could be used for more accurate 
staging of patients with routine effusions. (Folia Histochemica et Cytobiologica 2013, Vol. 51, No. 3, 201–205)
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Introduction
Malignant tumors are a common cause of exudates 
because the serosal surfaces are a frequent site of 
metastases of many tumors and the site of origin for 
malignant mesothelioma. Malignant pleural effusions 
(MPE) are common clinical problems in patients 
with neoplastic diseases (e.g. lung, breast, and ovary 
carcinoma, lymphomas, mesothelioma) [1].
Usually, if MPE is reported, a documented primary 
tumor is on record as well. However, in a fraction of 
cases, effusion is the first manifestation of an unknown 
primary tumor. Identifying the MPE origin is essential 
for appropriate staging and therapy [2]. The presence 
of MPE correlates with a higher stage of disease and 
worsens prognosis.
Pleural fluid cytology is the simplest definitive 
method for obtaining a diagnosis of MPE and it is 
more sensitive than blind biopsy for serosal malignan-
cy (71% versus 45%) [3]. However, sometimes the 
number of cancer cells is very low and the cells may 
be lost during the analytical procedures. The cancer 
detection rate may be increased from 2% to 38% 
when multiple specimens are examined by cytology 
[4–6]. This still leaves a substantial false-negative rate. 
According to statistics only 58% to 71% of MPE are 
diagnosed [3]. For patients with a strong clinical suspi-
cion of pleural disease and a negative cytology result, 
a thoracoscopy is the procedure of diagnostic choice. 
Thoracoscopy could be omitted, if for the diagnosis of 
MPE a more sensitive method of cancer cell capture 
would be used. An immunomagnetic separation was 
proposed as a more streamlined method for routine 
MPE analysis [7]. 
MPE represents an excellent source of a wide 
variety of cancer cell cultures. MPEs gave rise to in 
vitro cultures both in adherent and/or in spheroid 
conditions [1, 8]. It has been recently reported that 
cancer cells obtained from MPE and implanted into 
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SCID mice gave rise to metastasizing tumors, which 
suggests indirectly the presence of tumor initiating 
cells in the MPE [1]. 
Besides the potential of MPEs being an excellent 
source of in vitro cultures of cancer cells, the pleural 
invasion score is also a very useful prognostic indicator 
in lung cancer. In many cases, the cancer may exfoliate 
itself into the pleural cavity and may progress to MPE 
without invading the parietal pleura. Examining pleu-
ral lavage cytology (PLC) in clinical practice is useful 
for detecting occult pleural dissemination before the 
appearance of MPE. However, the contribution of 
PLC to TNM staging has not been clarified yet. Evi-
dence of PLC positive findings should be considered 
as supplemental information to the precise diagnosis 
of the pleural invasion score [9]. 
Therefore, one may conclude that any additional 
sensitivity of cancer cell isolation obtained from the 
pleural cavity is desirable. In this paper we report 
cancer cell capturing by immunomagnetic separation 
using paramagnetic beads with a mixture of antibodies 
bound on their surface. Three problems have been 
addressed by immmunomagnetic separation in our 
case report: (i) the detection of cancer cells using 
a mixture of antibodies, (ii) the verification of ma-
lignancy, (iii) the possibility of setting up in vitro 
cultures of the captured cancer cells which can later 
be used for downstream analysis e.g. chemosensitivity 
testing to personalize the cancer treatment.
Material and methods
Patients. Patient N1: A 61 year-old female with a cancer 
history was admitted because of right side pleural effusion 
of unknown origin. Two years earlier the patient underwent 
a left hemicolectomy and a hysterectomy for advanced co-
lorectal adenocarcinoma. The confirmation of malignancy 
would mean a worsening of the patient’s prognosis, but also 
a chance to target the chemotherapy. 
Patient N2: A 57 year-old female, with no cancer record, 
was admitted to the hospital because of pleural effusion. The 
detection of cancer cells by immunomagnetic separation 
would help in primary tumor diagnostics. Previous patient 
CT-scanning did not identify any primary tumor site. Sub-
sequently, she was diagnosed with advanced ovarian cancer.
Patient N3: A 56 year-old male was admitted because 
of advanced non-small cell lung cancer (NSCLC). On exa-
mination a pleural effusion was detected. Immunomagnetic 
separation was used for cancer cell enrichment from MPE to 
demonstrate the specificity of the bead-antibodies cocktail 
to bind surface molecules of lung cancer cells.
Cancer cell detection from malignant pleural effusion 
(MPE) by immunomagnetic separation. MPE (0.5–50 mL) 
was obtained by thoracic puncture. Erythrocytes were lysed by 
EL-buffer (Qiagen, Hamburg, Germany) and the remaining 
cells were pelleted by centrifugation and resuspended in 
1 mL of Phosphate Buffer Saline (PBS, Verviers, Belgium). Im-
munomagnetic beads (AdnaTestBreastCancerSelect™ and/
/or AdnaTestColonCancerSelect™, Adnagen, Langenhagen, 
Germany) were used for cancer cell enrichment from MPE. 
The AdnaTest™ enables the immunomagnetic enrichment 
of tumor cells via bead-bound antibodies against epithelial 
(BerP4) and tumor-associated antigen (MUC1). A slightly 
modified manufacturer’s protocol was applied. After 15 mi-
nutes of incubation at room temperature on the wheel rotator, 
the tube was placed in a Magnetic Particle Concentrator stand 
(DYNAL, Oslo, Norway), which caused the paramagnetic 
beads to attach to the wall of the tube. The attached cells 
were washed 3 times with 1 mL PBS.
In vitro cancer cell culture. The bead-captured live cel-
ls were then suspended in PBS or culture medium and 
analyzed immediately under microscopy (see Figure 1). 
The cancer cell cultures were further maintained in RPMI 
(Sigma-Aldrich, Schnelldorf, Germany) supplemented with 
10% (v/v) fetal bovine serum (FBS (Sigma), and antibiotics 
(penicillin-streptomycin and amphotericin (Sigma). When 
a semiconfluence was reached, the cells were stained directly 
in the culture flasks by May-Grünwald method (see Figures 
2 and 3). All microscopic observations were performed with 
TS100 inverted microscope (Nikon, Tokyo, Japan).
Results 
The antibody-coated magnetic beads (Adnatest™) bind 
to molecules (antigens) of the cell membrane. Then, 
according the manufacturer’s protocol, the captured 
cells can be isolated from peripheral blood by use of 
a magnetic field. The reported specificity of epithelial 
cell detection in peripheral blood is generally around 
90% for different types of cancer if using Adnatest™. 
Our results describe the use of immunomagnetic be-
ads for rapid isolation and visualization of cancer cells 
from MPE in the colon cancer in the patient (N1) with 
primary tumor resected two years ago, in the patient with 
an unknown primary tumor (N2), diagnosed later with 
advanced ovarian cancer and in the patient with advanced 
NSCLC (N3). In all three cases the cancer cells were 
detected within 30 minutes (see Figure 1–3). Variable 
starting volumes of MPE were used for the immunoma-
gnetic separation, but as reported in the methods section, 
the cell sediment obtained after erythrocyte lyses was 
resolved in all cases in the same volume of PBS (1 mL). 
The 1 mL of cell suspension was then incubated with 
10 µL of immunobeads in all presented cases.
The cancer cells, captured and visualized by cell 
surface-bound beads, were further propagated within 
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Figure 1. Cancer cells isolated from malignant pleural effusion — colorectal cancer (Patient N1). The cancer cells were 
captured by incubation with the immunomagnetic beads (indicated by arrows) and visualized 2 hours (A) and 4 hours (B) 
after the separation process (see Material and Methods). The immunomagnetic beads are distributed on the cell surface 
unevenly, showing a different surface molecule expression pattern. We can follow a cell adhesion process visible in Figure B
the enriched cancer cell fraction in vitro, until they re-
ached a semiconfluence state. The cell culture process 
usually took less than 14 days. The cells were further 
analyzed according to basic morphological features of 
cancer cells after May-Grünwald staining, i.e. the high 
nucleus/cytoplasm ratio, multiple nuclei and nucleoli, 
loss of contact inhibition and long term viability (see 
Figure 2, 3). It was found that the number of cells was 
high enough to prepare serial slides for further immu-
nohistochemical and mutational analysis if needed. 
Discussion
The idea of identifying malignant cells in bodily fluid 
specimens to assess the stage of cancer patients more 
accurately is quite old [1, 6, 7]. The primary aim of this 
Figure 2. Cancer cells isolated from pleural effusion – ovarian cancer (Patient N2). The cancer cells are shown after in 
vitro incubation (2 weeks), stained by May-Grünwald staining. In addition to other characteristics, malignancy has been 
confirmed by prominent nucleoli (see arrows) in a cell with 2 nuclei (A). A detail of cancer cells with 2 nuclei (B), growing 
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short study was to isolate a pure cancer cell fraction 
from the MPE of patients as quickly as possible. We 
focused on in vitro culturing of the captured cells for 
further downstream analysis. The MPE-diagnostic 
yield depends on factors such as the extent of the 
disease and the nature of the primary malignancy. 
Therefore, studies have shown a large variation in 
the diagnostic yields of MPE ranging from 62 to 90% 
cancer cell positivity [10, 11]. 
As previously mentioned, there is still a substantial 
false negativity rate in the standard diagnostics of MPE 
[6]. Therefore, the enrichment technique could help 
in more accurate staging by the initial procedures and 
spare subsequent diagnostic tests or procedures [7]. 
In this study, we have not attempted to estimate the 
sensitivity of the detection of malignant cells in fluid. 
Analyzing only a few cases we wanted to demonstrate 
that the isolation process could be accurate and fast.
Magnetic beads-based separation methods have 
been used in the past to enrich tumor cells from blood, 
bone marrow, PBMC (peripheral blood mononuclear 
cells) fraction, ascites and effusions [7, 12, 13]. The ba-
sic principle of this method is the use of paramagnetic 
beads that are bound to antibodies, most frequently 
Figure 3. In vitro cancer cells cultures gained from pleural effusion. Figure A represents the MPE-derived ovarian cancer 
cells (Patient N2) after 2 days in vitro. Figure B, C show cell cultures derived from the same patient, but from a MPE 
drained one year after the first MPE-drainage. Prominent nuclei and nucleoli are visible in Figure B. Figure D, E, F 
show cancer cells cultured from pleural effusion of NSCLC patient, stained by May-Grünwald method (Patient N3). The 
staining revealed typical cancer cell morphology (high nucleus/cytoplasm ratio, multinuclear stage and rigid cytoplasm 
structure)
EpCAM (Epithelial Cell Adhesion Molecule) and 
their ability to magnetic separation. EpCAMs were 
found to be expressed on the membrane of the ma-
jority of tumors of epithelial origin [14].
The recent reports have shown how variable the 
EpCAM expression can be, and, in conclusion, how 
cocktail of antibodies is eligible [15–18]. A combina-
tion of antibodies bound to the beads would enable 
the capturing of cancer cells, which do not necessarily 
express EpCAM as used in the Adnatest™ protocols. 
Cell membrane EpCAM expression may be reduced 
during the epithelial-mesenchymal transition (EMT) 
process, which is one of the ultimate conditions of 
the tumor dissemination process. Likewise, loss of 
EpCAM is coincident with vimentin overexpression 
(mesenchymal marker) in the MPE specimens [19]. 
Immunomagnetic separation, is very advantageous 
if there are further plans to work with the living cancer 
cells. It is possible to use these cells for viability testing 
(e.g. xCelligence System, Roche) or gene expression 
analysis. Other isolation protocols of disseminated 
tumor cells from body fluids do not make enrichment 
of living cancer cells possible with such specificity (e.g. 
gradient based separation methods).
A B C
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Other procedures, such as immunohistochemi-
cal staining with monoclonal antibodies as tumor 
markers, DNA and chromosome analysis have been 
proposed to further aid in the cytological diagnosis 
of MPE [20]. The relative high number of immuno-
magnetically enriched and cultured cancer cells can 
confirm the malignancy by several methods [7]. The 
cells are an enormous source of research material to 
be tested in relationship to guided oncological treat-
ment [21]. Effusions may offer a unique in situ milieu 
to establish a ‘pre-metastatic niche’ [1]. We expect 
that thanks to our methodology it will be possible to 
test the chemosensitivity of the in vitro grown patients’ 
MPE-enriched cells to recommend the most effective 
treatment. Furthermore, gene expression testing of 
enriched MPE-cancer cells may be used to detect 
multidrug resistance gene expression. Establishment 
of a model MPE-cancer cell culture may provide a 
better understanding of the role of MPE-cancer cells 
in metastasis with respect to the high therapeutic 
failure rates in patients with MPE.
In conclusion, we report a more streamlined me-
thod which makes it possible to isolate living cancer 
cells within 30 minutes without any impairment of cell 
proliferation capacity. The immunomagnetic separa-
tion of living cancer cells from MPE could be used 
for more accurate staging of patients with effusions.
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